Paper21393859
Hunk is required for HER2/neu-induced mammary tumorigenesis.
Yeh ES and 5 others. J Clin Invest, 2011. Cited by 32 papers, by iCite.
Cite this record
ConductScience Library. Hunk is required for HER2/neu-induced mammary tumorigenesis. Papers, record 21393859. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21393859
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gene Expression Regulation, Neoplastic | Major topic |
| Protein Kinases | Major topic |
| Protein Serine-Threonine Kinases | Major topic |
| Erb-b2 Receptor Tyrosine Kinases | Major topic |
| Animals | |
| Breast Neoplasms | |
| Cell Line, Transformed | |
| Cell Line, Tumor | |
| Female | |
| Humans | |
| Male | |
| Mammary Neoplasms, Animal | |
| Mice | |
| Mice, Transgenic | |
| Microscopy, Fluorescence | |
| Neoplasm Transplantation | |
| Proto-Oncogene Mas |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA093373 | NCI NIH HHS | United States | P30CA093373 | PubMed and NIH | NIH RePORTER |
| U01 CA141582 | NCI NIH HHS | United States | U01CA141582 | PubMed and NIH | NIH RePORTER |
| R01 CA098371 | NCI NIH HHS | United States | R01CA098371 | PubMed and NIH | NIH RePORTER |
| UO1 CA105490 | NCI NIH HHS | United States | U01CA105490 | PubMed and NIH | NIH RePORTER |
| R01 CA127917 | NCI NIH HHS | United States | R01CA127917 | PubMed and NIH | NIH RePORTER |
| U01 CA105490 | NCI NIH HHS | United States | U01CA105490 | PubMed and NIH | NIH RePORTER |
| F32 CA130313 | NCI NIH HHS | United States | F32CA130313 | PubMed and NIH | NIH RePORTER |
References98
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10482195 | Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin). | Semin Oncol | 1999 | https://conductscience.org/library/papers/10482195 | PubMed |
| 2 | 10913383 | Herceptin (trastuzamab) in advanced breast cancer. | Cancer Treat Rev | 2000 | https://conductscience.org/library/papers/10913383 | PubMed |
| 3 | 8421674 | The conserved lysine of the catalytic domain of protein kinases is actively involved in the phosphotransfer reaction and not required for anchoring ATP. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/8421674 | PubMed |
| 4 | 16027121 | Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity. | J Biol Chem | 2005 | https://conductscience.org/library/papers/16027121 | PubMed |
| 5 | 17890319 | IkappaB kinase alpha kinase activity is required for self-renewal of ErbB2/Her2-transformed mammary tumor-initiating cells. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17890319 | PubMed |
| 6 | 18955454 | Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer. | J Clin Oncol | 2008 | https://conductscience.org/library/papers/18955454 | PubMed |
| 7 | 15866171 | AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. | Mol Cell | 2005 | https://conductscience.org/library/papers/15866171 | PubMed |
| 8 | 7768349 | Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. | FASEB J | 1995 | https://conductscience.org/library/papers/7768349 | PubMed |
| 9 | 19690609 | A core MYC gene expression signature is prominent in basal-like breast cancer but only partially overlaps the core serum response. | PLoS One | 2009 | https://conductscience.org/library/papers/19690609 | PubMed |
| 10 | 18381417 | Phosphatase and tensin homologue deleted on chromosome 10 deficiency accelerates tumor induction in a mouse model of ErbB-2 mammary tumorigenesis. | Cancer Res | 2008 | https://conductscience.org/library/papers/18381417 | PubMed |
| 11 | 8012996 | Prognostic factors and response to therapy in breast cancer. | Cancer Surv | 1993 | https://conductscience.org/library/papers/8012996 | PubMed |
| 12 | 16369543 | A role for the scaffolding adapter GAB2 in breast cancer. | Nat Med | 2006 | https://conductscience.org/library/papers/16369543 | PubMed |
| 13 | 10742152 | Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets. | Nat Med | 2000 | https://conductscience.org/library/papers/10742152 | PubMed |
| 14 | 10662544 | Cloning and characterization of Hunk, a novel mammalian SNF1-related protein kinase. | Genomics | 2000 | https://conductscience.org/library/papers/10662544 | PubMed |
| 15 | 12228201 | Selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 is generally well-tolerated and has activity in non-small-cell lung cancer and other solid tumors: results of a phase I trial. | J Clin Oncol | 2002 | https://conductscience.org/library/papers/12228201 | PubMed |
| 16 | 16144086 | Cloning of short hairpin RNAs for gene knockdown in mammalian cells. | Nat Methods | 2004 | https://conductscience.org/library/papers/16144086 | PubMed |
| 17 | 16489017 | Reduction of cytosolic p27(Kip1) inhibits cancer cell motility, survival, and tumorigenicity. | Cancer Res | 2006 | https://conductscience.org/library/papers/16489017 | PubMed |
| 18 | 11522658 | ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways. | Cancer Res | 2001 | https://conductscience.org/library/papers/11522658 | PubMed |
| 19 | 3798106 | Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. | Science | 1987 | https://conductscience.org/library/papers/3798106 | PubMed |
| 20 | 11741534 | C-TAK1 regulates Ras signaling by phosphorylating the MAPK scaffold, KSR1. | Mol Cell | 2001 | https://conductscience.org/library/papers/11741534 | PubMed |
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40598530 | Hormonally upregulated neu tumor-associated kinase (HUNK) modulates gastric cancer progression through the regulation of cell homeostasis. | Cell Commun Signal | 2025 | https://conductscience.org/library/papers/40598530 | PubMed |
| 40441033 | Modulating hormonally upregulated neu-associated kinase (HUNK) activity in breast cancer: The development of HUNK inhibitors. | J Pharmacol Exp Ther | 2025 | https://conductscience.org/library/papers/40441033 | PubMed |
| 39455282 | Chronic interferon-stimulated gene transcription promotes oncogene-induced breast cancer. | Genes Dev | 2024 | https://conductscience.org/library/papers/39455282 | PubMed |
| 38846083 | HUNK as a key regulator of tumor-associated macrophages in triple negative breast cancer. | Oncoimmunology | 2024 | https://conductscience.org/library/papers/38846083 | PubMed |
| 38307028 | Identification and characterization of a potent and selective HUNK inhibitor for treatment of HER2+ breast cancer. | Cell Chem Biol | 2024 | https://conductscience.org/library/papers/38307028 | PubMed |
| 37193711 | HUNK inhibits epithelial-mesenchymal transition of CRC via direct phosphorylation of GEF-H1 and activating RhoA/LIMK-1/CFL-1. | Cell Death Dis | 2023 | https://conductscience.org/library/papers/37193711 | PubMed |
| 36551828 | HUNK Gene Alterations in Breast Cancer. | Biomedicines | 2022 | https://conductscience.org/library/papers/36551828 | PubMed |
| 33982062 | PRG2 and AQPEP are misexpressed in fetal membranes in placenta previa and percreta†. | Biol Reprod | 2021 | https://conductscience.org/library/papers/33982062 | PubMed |
| 32676513 | HUNK Signaling in Metastatic Breast Cancer. | Oncoscience | 2020 | https://conductscience.org/library/papers/32676513 | PubMed |
| 31597954 | HUNK phosphorylates EGFR to regulate breast cancer metastasis. | Oncogene | 2020 | https://conductscience.org/library/papers/31597954 | PubMed |
| 31438969 | Integral membrane protein 2A inhibits cell growth in human breast cancer via enhancing autophagy induction. | Cell Commun Signal | 2019 | https://conductscience.org/library/papers/31438969 | PubMed |
| 31343992 | Gene loci associated with insulin secretion in islets from non-diabetic mice. | J Clin Invest | 2019 | https://conductscience.org/library/papers/31343992 | PubMed |
| 30599775 | c-MYB and DMTF1 in Cancer. | Cancer Invest | 2019 | https://conductscience.org/library/papers/30599775 | PubMed |
| 30542510 | Staurosporine, an inhibitor of hormonally up-regulated neu-associated kinase. | Oncotarget | 2018 | https://conductscience.org/library/papers/30542510 | PubMed |
| 28189783 | Hormonally up-regulated neu-associated kinase: A novel target for breast cancer progression. | Pharmacol Res | 2017 | https://conductscience.org/library/papers/28189783 | PubMed |
| 27726101 | Lapatinib resistance in HER2+ cancers: latest findings and new concepts on molecular mechanisms. | Tumour Biol | 2016 | https://conductscience.org/library/papers/27726101 | PubMed |
| 27553713 | Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neu. | Int J Cancer | 2017 | https://conductscience.org/library/papers/27553713 | PubMed |
| 27045589 | Co-Targeting of JNK and HUNK in Resistant HER2-Positive Breast Cancer. | PLoS One | 2016 | https://conductscience.org/library/papers/27045589 | PubMed |
| 26899482 | TOM1L1 drives membrane delivery of MT1-MMP to promote ERBB2-induced breast cancer cell invasion. | Nat Commun | 2016 | https://conductscience.org/library/papers/26899482 | PubMed |
| 26496021 | Bisphenol A Disrupts HNF4α-Regulated Gene Networks Linking to Prostate Preneoplasia and Immune Disruption in Noble Rats. | Endocrinology | 2016 | https://conductscience.org/library/papers/26496021 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| HUNK | 30811 | PubTator's text mining | https://conductscience.org/library/genes/30811 | NCBI Gene |
| MYC | 4609 | PubTator's text mining | https://conductscience.org/library/genes/4609 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21393859
GET https://conductscience.org/api/papers/v1/21393859/references?page=2